The European Commission has granted approval for Bayer's cancer medication Nubeqa to be used in treating metastatic hormone-sensitive prostate cancer, marking a significant milestone for the ...

EEST Darolutamide receives EU approval in third indication for patients with advanced prostate cancer European Commission granted approval ...

OUR much-loved astrologer Meg sadly died in 2023 but her column will be kept alive by her friend and protégée . Read on to ...

The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

Prostate cancer tumor biology can differ significantly based on whether a patient is Black or white, according to data from a ...

Prostate cancer focal therapies include cryotherapy, irreversible electroporation ablation (IRE), & high-intensity focused ultrasound (HIFU).

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances ...

A large Department of Veterans Affairs cohort study revealed key racial differences in genomic alterations among men with metastatic prostate cancer.

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85% ...

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.